Transaction in Own Shares

Summary by AI BETAClose X

QinetiQ Group plc has purchased 143,533 of its ordinary shares on 4 December 2025 as part of its ongoing share buyback programme, with the highest price paid per share being 415.60 pence and the average price paid being 413.3309 pence. These shares are intended for cancellation, and following this transaction, the total number of ordinary shares in issue will be 533,622,719, with no shares held in treasury. This reduction in outstanding shares may impact future earnings per share calculations for shareholders.

Disclaimer*

QinetiQ Group plc
05 December 2025
 

QinetiQ Group plc

5 December 2025

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that on 4 December 2025 it has purchased, in accordance with the authority granted by shareholders at the annual general meeting of the Company held on 17 July 2025, the following number of its ordinary shares of 1 pence each (Shares) on the London Stock Exchange, pursuant to the latest tranche of its existing share buyback programme the commencement of which was announced on 17 November 2025

The Company intends to cancel the purchased shares.

Description of Shares:

QinetiQ Group plc- ordinary shares of 1 pence each (ISIN: GB00B0WMWD03)

Date of transaction

4 December 2025

Number of Shares purchased:

143,533

Highest price paid per Share (pence):

415.60

Lowest price paid per Share (pence):

410.60

Average price paid per Share (pence):

413.3309

Broker:

Deutsche Bank AG, London Branch (trading for these purposes as Deutsche Numis) ("Deutsche Numis")

 

 

Aggregate information:                                                                                  

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

London Stock Exchange

413.2991

                        71,000

410.60

415.60

Chi-X

(CXE)

413.3708

                        23,000

411.00

415.60

BATS (BXE)

413.3580

                        49,533

410.80

415.60

 

This announcement is prepared on a trade basis. It is expected the shares purchased will be delivered to the Company within two working days. The total voting rights referred to below is prepared on a settlement basis.

Following the purchase of these shares, the remaining number of ordinary shares in issue will be 533,622,719. The Company does not hold any ordinary shares in treasury. Therefore, the total voting rights in the Company will be 533,622,719. This figure may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a. change to their interest in, the Company under the Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, a full breakdown of the individual trades made by Deutsche Numis on behalf of the Company is available via the link below.

 

 http://www.rns-pdf.londonstockexchange.com/rns/3521K_1-2025-12-4.pdf

 

This announcement will also be available on QinetiQ Group plc's website at https://www.qinetiq.com/en/investors.

Enquiries to:

Stephen Lamacraft, Interim Group Investor Relations Director:

+44 (0) 7920 545841

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

 

LEI: 213800S8OBDOZMCMUW34

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings